May 28 |
GSK plc: Long-Term Cash Cow
|
May 27 |
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
|
May 24 |
Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit
|
May 23 |
GSK wins first Zantac cancer jury trial (updated)
|
May 22 |
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
|
May 22 |
GSK Breathes New Life Into Asthma Treatment With Depemokimab
|
May 22 |
Australia reports first human case of bird flu
|
May 21 |
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
|
May 21 |
European Stocks Decline as Investors Eye Nvidia, Rates Outlook
|
May 21 |
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
|